A four-gene signature predicts survival and anti-CTLA4 immunotherapeutic responses based on immune classification of melanoma is a research paper published in Communications Biology (2021). On theSindex it has a DataRank of 0. It has been cited 28 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
U.S. Department of Health & Human Services | NIH | National Cancer Institute
Grant: R01CA166051
U.S. Department of Health & Human Services | NIH | National Cancer Institute
Grant: R01CA181029
Cancer Prevention and Research Institute of Texas
Grant: RP190029
NCI NIH HHS
Grant: P50 CA221703
National Institutes of Health
Grant: 5P50CA221703-04
The University of Texas MD Anderson Cancer Center SPORE in Melanoma
National Institutes of Health
Grant: 5R01CA166051-03
Regulation of metastasis and epithelial-mesenchymal transition by microRNAs
National Institutes of Health
Grant: 5R01CA181029-04
Epithelial-mesenchymal transition regulators in radioresistance and DNA repair
U.S. Department of Health & Human Services | NIH | National Cancer Institute
FWCI
1.86
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals